🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

TOETVA Technique Compared With Anterior Cervical Thyroidectomy (AC) in Terms of Efficacy and Safety

RecruitingNAAges 18 Years - 65 YearsAllUniversity Hospital, Lille
NCT07055191 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Nearly 50,000 thyroidectomies are performed in France each year for benign and malignant pathologies. Each one affects the life of the patient and represents, for some, suffering, symbolized by the stigma of the operation. The consequences of these scars vary according to the patient, their experience and their culture. For example, cervicotomies are particularly badly accepted in Asia since they are supposed to interrupt the fertility meridian. In France, increasing attention is being paid to the global management of a person with some disease. As a disease state may be transitory, the medical team must consider the situation "after the illness" and plan a return to normality. In particular, alternative approaches to cervicotomy have been developed, in which the scar is in a less visible location, at the cost of a more extensive dissection. These techniques include the transaxillary app

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with a surgical indication for lobectomy or thyroidectomy * Estimated thyroid volume measured by ultrasonography of less than 60 mL * Nodules suspected to be malignant measuring less than 4 cm * Patient aged between 18 and 65 years old * Patient who has benefited from an endocrinological evaluation, with a favorable opinion for TOETVA or AC Patient who understands and accepts the need for follow-up * Patient who agrees to be included in the study and who signs the informed consent form * Patient affiliated to a healthcare insurance plan Exclusion Criteria: * Patients refusing an alternative to AC or refusing AC * History of cervical surgery * Associated parathyroid surgery * Identification of malignant lymph nodes * Presence of a severe and evolutive life threatening pathology * Patients with unstable psychiatric disorder, under supervision or guardianship * Patient who does not understand French/ is unable to give consent * Patient not affiliated to a French or European healthcare insurance * Patient who has already been included in a trial which has a conflict of interests with the present study * Pregnant or breast-feeding patient * Patient incarcerated
💊

What it tests

  • Transoral Endoscopic Thyroidectomy by Vestibular Approach
  • Anterior Cervical thyroidectomy
📍

Where

10 sites
AP-HP - Hôpital Avicennes
Bobigny, France
Hôpital Franco-Britannique
Levallois-Perret, France
CHU de Lille, Hôpital Huriez
Lille, France
CHU Dupuytren
Limoges, France
CHU de Nantes - Hôtel Dieu
Nantes, France
AP-HP - Hôpital Cochin
Paris, France
Hôpital Lyon Sud
Pierre-Bénite, France
CHU de Poitiers
Poitiers, France

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy